Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group
- PMID: 9798025
- DOI: 10.1086/514934
Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group
Abstract
In this prospective, multicenter, double-blind study, the efficacy of ciprofloxacin was compared with that of clarithromycin as therapy for patients with acute bacterial exacerbations of chronic bronchitis (ABECB) from whom a pretherapy pathogen was isolated; the efficacy was measured by the infection-free interval. Clinical and microbiological responses at the end of therapy were secondary efficacy variables. Patients randomly received either ciprofloxacin or clarithromycin (500 mg twice a day for 14 days). Three hundred seventy-six patients with acute exacerbations of chronic bronchitis were enrolled in the study of whom 234 had an ABECB. Clinical resolution was observed in 90% (89 of 99) of ciprofloxacin recipients and 82% (75 of 91) of clarithromycin recipients for whom efficacy could be evaluated. The median infection-free interval was 142 days for ciprofloxacin recipients and 51 days for clarithromycin recipients (P = .15). Bacteriologic eradication rates were 91% (86 of 95) for ciprofloxacin recipients and 77% (67 of 87) for clarithromycin recipients (P = .01). In summary, compared with clarithromycin, treatment of ABECB with ciprofloxacin was associated with a trend toward a longer infection-free interval and a statistically significantly higher bacteriologic eradication rate.
Comment in
-
The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis.Clin Infect Dis. 1999 Jun;28(6):1344-5. doi: 10.1086/517802. Clin Infect Dis. 1999. PMID: 10451195 No abstract available.
Similar articles
-
Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.Clin Infect Dis. 1998 Oct;27(4):722-9. doi: 10.1086/514930. Clin Infect Dis. 1998. PMID: 9798024 Clinical Trial.
-
Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group.Clin Ther. 1997 Sep-Oct;19(5):989-1001. doi: 10.1016/s0149-2918(97)80051-3. Clin Ther. 1997. PMID: 9385486 Clinical Trial.
-
Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.Clin Ther. 1999 Jun;21(6):954-65. doi: 10.1016/S0149-2918(99)80017-4. Clin Ther. 1999. PMID: 10440620 Clinical Trial.
-
Clinical significance of the infection-free interval in the management of acute bacterial exacerbations of chronic bronchitis.Chest. 2005 Jun;127(6):2231-6. doi: 10.1378/chest.127.6.2231. Chest. 2005. PMID: 15947342 Review.
-
[Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis].Presse Med. 2001 Oct 27;30(31 Pt 2):17-22. Presse Med. 2001. PMID: 11721486 Review. French.
Cited by
-
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Eur J Clin Pharmacol. 2012 May;68(5):479-503. doi: 10.1007/s00228-011-1161-x. Epub 2011 Nov 22. Eur J Clin Pharmacol. 2012. PMID: 22105373 Review.
-
Levofloxacin inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells.Antimicrob Agents Chemother. 2012 Aug;56(8):4052-61. doi: 10.1128/AAC.00259-12. Epub 2012 May 14. Antimicrob Agents Chemother. 2012. PMID: 22585227 Free PMC article.
-
Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones.Clin Microbiol Infect. 2006 May;12 Suppl 3(Suppl 3):42-54. doi: 10.1111/j.1469-0691.2006.01396.x. Clin Microbiol Infect. 2006. PMID: 16669928 Free PMC article. Review.
-
Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.Clin Microbiol Rev. 2001 Apr;14(2):336-63. doi: 10.1128/CMR.14.2.336-363.2001. Clin Microbiol Rev. 2001. PMID: 11292642 Free PMC article. Review.
-
Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media.Antimicrob Agents Chemother. 2000 Sep;44(9):2590-2. doi: 10.1128/AAC.44.9.2590-2592.2000. Antimicrob Agents Chemother. 2000. PMID: 11012390 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical